Pacific Biosciences
PACB
$1.46
Share price
4.29%
Change (1 day)
-86.59%
Change (1 year)
Categories
P/S ratio for Pacific Biosciences (PACB)
P/S ratio as of April 2024 (TTM): 1.95
According to Pacific Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.95097. At the end of 2023 the company had a P/S ratio of 13.1.
P/S ratio history for Pacific Biosciences from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 13.1 | -9.24% |
| 2022 | 14.4 | -58.32% |
| 2021 | 34.6 | -43.82% |
| 2020 | 61.6 | 610.92% |
| 2019 | 8.66 | -38.76% |
| 2018 | 14.1 | 330.65% |
| 2017 | 3.28 | -15.4% |
| 2016 | 3.88 | -65.71% |
| 2015 | 11.3 | 18.33% |
| 2014 | 9.57 | -22.24% |
| 2013 | 12.3 | 234.69% |
| 2012 | 3.68 | -18.91% |
| 2011 | 4.53 | -99.1% |
| 2010 | 502 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.82 | 147.22% | 🇺🇸 USA |
 General Electric GE | 2.46 | 26.12% | 🇺🇸 USA |
 Illumina ILMN | 4.13 | 111.48% | 🇺🇸 USA |
 PerkinElmer
PKI | 4.31 | 120.69% | 🇺🇸 USA |
 Luminex LMNX | N/A | N/A | 🇺🇸 USA |
 NanoString Technologies NSTG | 0.0312 | -98.40% | 🇺🇸 USA |